Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma. A preliminary experience with 27 patients.
BACKGROUND
Radiofrequency ablation (RFA), currently used extensively for liver tumors, also has been applied successfully to hepatic cavernous hemangioma (HCH) percutaneously. The aim of this study was to assess the feasibility, safety, and efficacy of laparoscopic RFA for patients with HCHs.


METHODS
Between March 2001 and March 2004, 27 patients with symptomatic and rapid-growth lesions were treated by laparoscopic RFA using the RF-2000 generator system. The treatment-related complications were observed. All the patients were followed up with helical computed tomography scans and ultrasonography at regular intervals to assess the therapeutic efficacy of laparoscopic RFA.


RESULTS
This study assessed 9 men and 18 women with a mean age of 41.6 +/- 8.3 years. Three additional intrahepatic lesions missed preoperatively were found in three patients on intraoperative ultrasound. A total of 27 patients with 50 liver lesions were treated successfully with laparoscopic RFA. The mean maximum tumor diameter was 5.5 +/- 2.0 cm. The mean length of time for RFA per lesion was 20.7 +/- 11.9 min, and the mean blood loss was 134.4 +/- 88.9 ml. Laparoscopic cholecystectomy was performed simultaneously for gallstones in 13 patients and for abutting of gallbladder from hemangioma in 2 patients. In addition, 3 patients also had a laparoscopic deroofing of simple hepatic cysts. Although postoperative low-grade fever and transient elevation of serum transaminase levels were observed in 13 patients, there were no complications related to laparoscopic RFA. During a median follow-up period of 21 months (range, 12-42 months), complete lesion necrosis was achieved for all the patients.


CONCLUSIONS
Laparoscopic RFA therapy is a safe, feasible, and effective treatment option for patients with symptomatic and rapid-growth HCHs located on the surface of the liver or adjacent to the gallbladder. Intraoperative ultrasonography is a useful adjunct for detecting additional liver lesions and offering more accurate targeting for RFA.
Fan
R-F
RF
Department of Hepatobiliary Surgery, Lanzhou General Hospital of Lanzhou Military Region, People's Liberation Army, No. 58 Western Xiaoxihu Street, Lanzhou, 730050, Gansu, People's Republic of China. fanruifang@yahoo.com.cn
Chai
F-L
FL
He
G-X
GX
Wei
L-X
LX
Li
R-Z
RZ
Wan
W-X
WX
Bai
M-D
MD
Zhu
W-K
WK
Cao
M-L
ML
Li
H-M
HM
Yan
S-Z
SZ
D000328:Adult; D017115:Catheter Ablation / Q000009:adverse effects; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006392:Hemangioma, Cavernous / Q000601:surgery*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D008099:Liver / Q000000981:diagnostic imaging; D008113:Liver Neoplasms / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures; D036542:Tomography, Spiral Computed; D016896:Treatment Outcome; D014463:Ultrasonography